Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The P2X7 Receptor: Central Hub of Brain Diseases.
Andrejew R, Oliveira-Giacomelli Á, Ribeiro DE, Glaser T, Arnaud-Sampaio VF, Lameu C, Ulrich H. Andrejew R, et al. Front Mol Neurosci. 2020 Jul 31;13:124. doi: 10.3389/fnmol.2020.00124. eCollection 2020. Front Mol Neurosci. 2020. PMID: 32848594 Free PMC article. Review.
Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology.
Ribeiro DE, Oliveira-Giacomelli Á, Glaser T, Arnaud-Sampaio VF, Andrejew R, Dieckmann L, Baranova J, Lameu C, Ratajczak MZ, Ulrich H. Ribeiro DE, et al. Among authors: andrejew r. Mol Psychiatry. 2021 Apr;26(4):1044-1059. doi: 10.1038/s41380-020-00965-3. Epub 2020 Dec 16. Mol Psychiatry. 2021. PMID: 33328588 Free PMC article. Review.
Antagonistic Roles of P2X7 and P2Y2 Receptors in Neurodegenerative Diseases.
Glaser T, Oliveira-Giacomelli Á, Petiz LL, Ribeiro DE, Andrejew R, Ulrich H. Glaser T, et al. Among authors: andrejew r. Front Pharmacol. 2021 Apr 12;12:659097. doi: 10.3389/fphar.2021.659097. eCollection 2021. Front Pharmacol. 2021. PMID: 33912064 Free PMC article. No abstract available.
Role of P2X7 Receptors in Immune Responses During Neurodegeneration.
Oliveira-Giacomelli Á, Petiz LL, Andrejew R, Turrini N, Silva JB, Sack U, Ulrich H. Oliveira-Giacomelli Á, et al. Among authors: andrejew r. Front Cell Neurosci. 2021 May 26;15:662935. doi: 10.3389/fncel.2021.662935. eCollection 2021. Front Cell Neurosci. 2021. PMID: 34122013 Free PMC article. Review.
Dysfunctional purinergic signaling correlates with disease severity in COVID-19 patients.
Pietrobon AJ, Andrejew R, Custódio RWA, Oliveira LM, Scholl JN, Teixeira FME, de Brito CA, Glaser T, Kazmierski J, Goffinet C, Turdo AC, Yendo T, Aoki V, Figueiró F, Battastini AM, Ulrich H, Benard G, Duarte AJDS, Sato MN. Pietrobon AJ, et al. Among authors: andrejew r. Front Immunol. 2022 Sep 30;13:1012027. doi: 10.3389/fimmu.2022.1012027. eCollection 2022. Front Immunol. 2022. PMID: 36248842 Free PMC article.
Purinergic signaling in cognitive impairment and neuropsychiatric symptoms of Alzheimer's disease.
Ribeiro DE, Petiz LL, Glaser T, Oliveira-Giacomelli Á, Andrejew R, Saab FAR, Milanis MDS, Campos HC, Sampaio VFA, La Banca S, Longo BM, Lameu C, Tang Y, Resende RR, Ferreira ST, Ulrich H. Ribeiro DE, et al. Among authors: andrejew r. Neuropharmacology. 2023 Mar 15;226:109371. doi: 10.1016/j.neuropharm.2022.109371. Epub 2022 Dec 9. Neuropharmacology. 2023. PMID: 36502867 Review.
Exploring CD39 and CD73 Expression as Potential Biomarkers in Prostate Cancer.
Gardani CFF, Pedrazza EL, Paz VS, Zanirati GG, da Costa JC, Andrejew R, Ulrich H, Scholl JN, Figueiró F, Rockenbach L, Morrone FB. Gardani CFF, et al. Among authors: andrejew r. Pharmaceuticals (Basel). 2023 Nov 16;16(11):1619. doi: 10.3390/ph16111619. Pharmaceuticals (Basel). 2023. PMID: 38004484 Free PMC article.
18 results